APYX
Price
$1.99
Change
-$0.03 (-1.49%)
Updated
Aug 29 closing price
Capitalization
75.26M
67 days until earnings call
ESTA
Price
$41.27
Change
+$0.27 (+0.66%)
Updated
Aug 29 closing price
Capitalization
1.2B
72 days until earnings call
Interact to see
Advertisement

APYX vs ESTA

Header iconAPYX vs ESTA Comparison
Open Charts APYX vs ESTABanner chart's image
Apyx Medical
Price$1.99
Change-$0.03 (-1.49%)
Volume$17.89K
Capitalization75.26M
Establishment Labs Holdings
Price$41.27
Change+$0.27 (+0.66%)
Volume$205.8K
Capitalization1.2B
APYX vs ESTA Comparison Chart in %
Loading...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APYX vs. ESTA commentary
Aug 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a Hold and ESTA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 31, 2025
Stock price -- (APYX: $1.99 vs. ESTA: $41.27)
Brand notoriety: APYX and ESTA are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: APYX: 18% vs. ESTA: 52%
Market capitalization -- APYX: $75.26M vs. ESTA: $1.2B
APYX [@Medical/Nursing Services] is valued at $75.26M. ESTA’s [@Medical/Nursing Services] market capitalization is $1.2B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.89B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APYX’s FA Score shows that 0 FA rating(s) are green whileESTA’s FA Score has 0 green FA rating(s).

  • APYX’s FA Score: 0 green, 5 red.
  • ESTA’s FA Score: 0 green, 5 red.
According to our system of comparison, APYX is a better buy in the long-term than ESTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APYX’s TA Score shows that 1 TA indicator(s) are bullish while ESTA’s TA Score has 6 bullish TA indicator(s).

  • APYX’s TA Score: 1 bullish, 8 bearish.
  • ESTA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ESTA is a better buy in the short-term than APYX.

Price Growth

APYX (@Medical/Nursing Services) experienced а -4.78% price change this week, while ESTA (@Medical/Nursing Services) price change was -5.42% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.77%. For the same industry, the average monthly price growth was +6.45%, and the average quarterly price growth was +9.91%.

Reported Earning Dates

APYX is expected to report earnings on Nov 06, 2025.

ESTA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical/Nursing Services (+0.77% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESTA($1.2B) has a higher market cap than APYX($75.3M). APYX YTD gains are higher at: 25.949 vs. ESTA (-10.419). APYX has higher annual earnings (EBITDA): -10.64M vs. ESTA (-54.68M). ESTA has more cash in the bank: 54.6M vs. APYX (29.3M). APYX has less debt than ESTA: APYX (39.1M) vs ESTA (231M). ESTA has higher revenues than APYX: ESTA (177M) vs APYX (46.5M).
APYXESTAAPYX / ESTA
Capitalization75.3M1.2B6%
EBITDA-10.64M-54.68M19%
Gain YTD25.949-10.419-249%
P/E RatioN/AN/A-
Revenue46.5M177M26%
Total Cash29.3M54.6M54%
Total Debt39.1M231M17%
FUNDAMENTALS RATINGS
APYX vs ESTA: Fundamental Ratings
APYX
ESTA
OUTLOOK RATING
1..100
308
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
10072
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4255
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APYX's Valuation (54) in the Medical Specialties industry is in the same range as ESTA (63). This means that APYX’s stock grew similarly to ESTA’s over the last 12 months.

ESTA's Profit vs Risk Rating (72) in the Medical Specialties industry is in the same range as APYX (100). This means that ESTA’s stock grew similarly to APYX’s over the last 12 months.

APYX's SMR Rating (99) in the Medical Specialties industry is in the same range as ESTA (100). This means that APYX’s stock grew similarly to ESTA’s over the last 12 months.

APYX's Price Growth Rating (42) in the Medical Specialties industry is in the same range as ESTA (55). This means that APYX’s stock grew similarly to ESTA’s over the last 12 months.

APYX's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as ESTA (100). This means that APYX’s stock grew similarly to ESTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APYXESTA
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 10 days ago
87%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 13 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAPAX9.18-0.02
-0.22%
Federated Hermes Capital Income A
EMFIX12.84-0.03
-0.23%
Ashmore Emerging Markets Equity Instl
SNWCX60.07-0.21
-0.35%
Easterly Snow Small Cap Value C
MSRRX59.69-0.28
-0.47%
MFS Research R2
ACFDX74.19-0.82
-1.09%
American Century Focused Dynamic Gr A

APYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, APYX has been loosely correlated with CORBF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APYX jumps, then CORBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APYX
1D Price
Change %
APYX100%
-1.49%
CORBF - APYX
36%
Loosely correlated
N/A
CLPT - APYX
26%
Poorly correlated
N/A
INGN - APYX
26%
Poorly correlated
+0.38%
EMBC - APYX
25%
Poorly correlated
+0.91%
INFU - APYX
25%
Poorly correlated
+0.47%
More